JP2008515980A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515980A5
JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
Authority
JP
Japan
Prior art keywords
osamu
prostaglandins
prevention
ester
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007536818A
Other languages
English (en)
Other versions
JP2008515980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036558 external-priority patent/WO2006044405A1/en
Publication of JP2008515980A publication Critical patent/JP2008515980A/ja
Publication of JP2008515980A5 publication Critical patent/JP2008515980A5/ja
Pending legal-status Critical Current

Links

Claims (2)

  1. プロスタグランジン媒介疾患又は病態の治療又は予防のための医薬組成物の製造における、請求項1に記載の化合物、又はそのエステルの使用。
  2. 薬学的に許容可能な担体と、請求項1に記載の化合物とを含む医薬製剤
JP2007536818A 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 Pending JP2008515980A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61820204P 2004-10-12 2004-10-12
PCT/US2005/036558 WO2006044405A1 (en) 2004-10-12 2005-10-11 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease

Publications (2)

Publication Number Publication Date
JP2008515980A JP2008515980A (ja) 2008-05-15
JP2008515980A5 true JP2008515980A5 (ja) 2008-11-27

Family

ID=35677621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536818A Pending JP2008515980A (ja) 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物

Country Status (17)

Country Link
US (2) US20060142348A1 (ja)
EP (1) EP1812426B1 (ja)
JP (1) JP2008515980A (ja)
KR (1) KR20070085340A (ja)
CN (1) CN101076529A (ja)
AT (1) ATE512144T1 (ja)
AU (1) AU2005295902A1 (ja)
BR (1) BRPI0517417A (ja)
CA (1) CA2583710A1 (ja)
HK (1) HK1110580A1 (ja)
IL (1) IL182489A0 (ja)
MX (1) MX2007004526A (ja)
NO (1) NO20072269L (ja)
NZ (1) NZ554493A (ja)
RU (1) RU2407736C2 (ja)
SG (1) SG156637A1 (ja)
WO (1) WO2006044405A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
DK1928454T3 (da) 2005-05-10 2014-11-03 Intermune Inc Pyridonderivater til modulering af stress-aktiveret proteinkinasesystem
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
ES2567283T3 (es) 2008-06-03 2016-04-21 Intermune, Inc. Compuestos y métodos para tratar trastornos inflamatorios y fibróticos
FR2938538B1 (fr) * 2008-11-17 2011-08-05 Univ Nice Sophia Antipolis Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique
AU2010232729A1 (en) 2009-03-31 2011-10-20 Arqule, Inc. Substituted indolo-pyridinone compounds
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015048553A1 (en) * 2013-09-27 2015-04-02 Allergan, Inc. Compounds and methods for skin repair
KR102373700B1 (ko) 2014-04-02 2022-03-11 인터뮨, 인크. 항섬유성 피리디논
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
PE20220808A1 (es) 2019-06-18 2022-05-20 Pfizer Derivados de benzisoxazol sulfonamida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69609602T2 (de) * 1995-04-03 2001-04-12 Novartis Ag Pyrazolderivate und verfahren zu deren herstellung
ZA984040B (en) * 1997-05-15 1998-11-20 Ono Pharmaceutical Co Benzenesulfonamide compounds
ES2253266T3 (es) * 1999-11-30 2006-06-01 Pfizer Products Inc. Compuestos de 2,4-diaminopirimidina utiles como inmunosupresores.
EP1431267A4 (en) * 2001-08-09 2004-12-22 Ono Pharmaceutical Co COMPOUNDS DERIVED FROM CARBOXYLIC ACID AND MEDICAMENTS COMPRISING SUCH COMPOUNDS AS ACTIVE INGREDIENT
JPWO2004078719A1 (ja) * 2003-03-06 2006-06-08 小野薬品工業株式会社 インドール誘導体化合物およびその化合物を有効成分とする薬剤
WO2005005415A1 (en) * 2003-07-09 2005-01-20 Biolipox Ab Indoles useful in the treatment of inflammation
DK1696920T3 (en) * 2003-12-19 2015-01-19 Plexxikon Inc RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS

Similar Documents

Publication Publication Date Title
JP2008515980A5 (ja)
JP2007501251A5 (ja)
JP2007520565A5 (ja)
JP2003520232A5 (ja)
JP2008513510A5 (ja)
JP2003503454A5 (ja)
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
JP2007514005A5 (ja)
JP2012502037A5 (ja)
JP2006517944A5 (ja)
CL2007001992A1 (es) Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege
JP2010528011A5 (ja)
JP2009538898A5 (ja)
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
JP2008505857A5 (ja)
JP2007523135A5 (ja)
WO2007093642A3 (fr) Formes pharmaceutiques multimicroparticulaires qui resistent a la decharge immediate du principe actif en presence d'alcool
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
JP2009537554A5 (ja)
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
JP2007238598A5 (ja)
JP2005513006A5 (ja)
DE602008006243D1 (de) Pharmazeutische kombination aus aliskiren und valsartan
JP2003526626A5 (ja)